Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Ming Xu 1,2 , Changhong Zhu 2 , Xian Zhao 2 , Cheng Chen 2 , Hailong Zhang 2 , Haihua Yuan 1 , Rong Deng 2 , Jinzhuo Dou 2 , Yanli Wang 2 , Jian Huang 2 , Qin Chen 2 , Bin Jiang 1 and Jianxiu Yu 2,3 1 Institute of Oncology & Department of Oncology, Shanghai 9th People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 2 Department of Biochemistry and Molecular Cell Biology & Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China 3 State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China Correspondence: Jianxiu Yu, email: // Keywords : Epithelial-mesenchymal transition (EMT), EMT-Inducing Transcription Factors (EMT-TFs), Fbxo45; miR-27a*, ubiquitin degradation Received : August 05, 2014 Accepted : November 24, 2014 Published : November 25, 2014 Abstract Epithelial-mesenchymal transition (EMT) plays a critical role in the development of tumor metastases by enhancing migration/invasion. One of the hallmarks of EMT is loss of E-cadherin and gain of N-cadherin expression, which are regulated by the core EMT-inducing transcription factors (EMT-TFs), such as Zeb1/2, Snai1/2 and Twist1. Here, we find that EMT-TFs can be dynamically degraded by an atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 (SPF Fbxo45 ) through the ubiquitin proteasome system (UPS). The key step is recognition of EMT-TFs by Fbxo45 through its SPRY domain for Zeb2, or F-box domain for the other three EMT-TFs Snai1, Snai2 and Twist1, respectively. The K48-linkaged ubiquitination capability on Zeb2 relies on its functional SBD domain. In addition, miR-27a* can directly down-regulate the expression of Fbxo45, preventing degradation of EMT-TFs and thus ensuring EMT phenotype. We suggest that Fbxo45 is a key node of the miR-27a*/Fbxo45/EMT-TFs signaling axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487 · cited 1×
“In the past few decades, many scientists in the world have focused on the core EMT-TFs and their regulatory networks during cancer initiation and progression [11, 53], however, the underlying mechanisms have not been fully elucidated.”
BackgroundZhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 1×
“The stability of Snai1 has been confirmed to be mediated through ubiquitin-proteasome system [40].”
BackgroundThe SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114 · cited 1×
“The Skp, Cullin and F-box containing complex ( i.e. , SCF complex) is a multisubunit E3 ubiquitin ligase catalyzing the ubiquitination of proteins destined for proteasomal degradation [32].”
BackgroundUbiquitin in the immune system
Zinngrebe, J., Montinaro, A., Peltzer, N., & Walczak, H. (2014) · The EMBO Reports · doi:10.1002/embr.201338025 · Cited by 227
SnapShot: The Epithelial-Mesenchymal Transition
Sleeman, J. P., & Thiery, J. P. (2011) · Cell · doi:10.1016/j.cell.2011.03.029 · Cited by 130
Proteomic analysis of the NOS2 interactome in human airway epithelial cells
Foster, M. W., Thompson, J. W., Forrester, M. T., Sha, Y., McMahon, T. J., Bowles, D. E., Moseley, M. A., & Marshall, H. E. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.02.079 · Cited by 25 · cited 1×
“We also demonstrate that Fbxo45 could recognize diverse substrates ( e.g ., Zeb2) mainly depends on its SPRY domain, which is in line with the previous reports [37, 56].”
Result
Cited by
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Wu, Y., Yang, X., Chen, Z., Tian, L., Jiang, G., Chen, F., Li, J., An, P., Lu, L., Luo, N., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1014-2 · Cited by 392
Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
Tsubakihara, Y., & Moustakas, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113672 · Cited by 160
van Staalduinen, J., Baker, D., ten Dijke, P., & van Dam, H. (2018) · Oncogene · doi:10.1038/s41388-018-0378-x · Cited by 158
The multiverse nature of epithelial to mesenchymal transition
Simeone, P., Trerotola, M., Franck, J., Cardon, T., Marchisio, M., Fournier, I., Salzet, M., Maffia, M., & Vergara, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.004 · Cited by 98
Metadata
- Authors
- Xu, M., Zhu, C., Zhao, X., Chen, C., Zhang, H., Yuan, H., Deng, R., Dou, J., Wang, Y., Huang, J., Chen, Q., Jiang, B., & Yu, J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-11-25
- Volume
- 6
- Issue
- 2
- Pages
- 979-994
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1498143688
- Cited by
- 88
- References
- 6
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. https://app.cochat.ai/papers/10.18632/oncotarget.2825
- The paper
- Xu, M., Zhu, C., Zhao, X., Chen, C., Zhang, H., Yuan, H., Deng, R., Dou, J., Wang, Y., Huang, J., Chen, Q., Jiang, B., & Yu, J. (2015). Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. https://doi.org/10.18632/oncotarget.2825
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.